Clinic
Mountain Peoples Health Councils INC
Mountain Peoples Health Councils INC was paid $3.19M by Medicaid between Jan 2018 and Dec 2024, across 56 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 38% of everything it billed.
33Billing provider infoMOUNTAIN PEOPLES HEALTH COUNCILS INC
ROBBINS, TN 37852
ROBBINS, TN 37852
33aNPI1962403428assigned 08/09/2005
33bProvider typeFederally Qualified Health Center (FQHC)
28Total paid$3.19M
24GClaims145,587
24DCodes billed56
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Federally Qualified Health Center (FQHC) providers in Tennessee
Rank by total paid#10 of 90
Median peer was paid$87K
This provider vs. median37×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 15,202 | $321K | |
| 2019 | 18,080 | $365K | |
| 2020 | 14,342 | $318K | |
| 2021 | 20,979 | $518K | |
| 2022 | 24,612 | $531K | |
| 2023 | 27,110 | $591K | |
| 2024incomplete | 25,262 | $547K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 38% | 37,145 | 28,924 | $1.21M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 34% | 24,967 | 19,115 | $1.07M |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | 6.9% | 13,762 | 9,785 | $220K |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | 6.8% | 19,205 | 15,552 | $216K |
| 99215 | Doctor's office visit, returning patient (complex)Prolong outpt/office vis | 3.9% | 2,096 | 1,562 | $126K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | 3.0% | 8,583 | 3,416 | $97K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 1.3% | 1,375 | 797 | $42K |
| 90832 | Psychotherapy session, about 30 minutesPsychotherapy, 30 minutes with patient | <1% | 1,384 | 853 | $32K |
| 80305 | <1% | 5,080 | 3,821 | $29K | |
| 96127 | <1% | 4,201 | 1,897 | $23K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 3,291 | 2,620 | $19K |
| G0467 | Community health center visit, returning patientFederally qualified health center (fqhc) visit, established patient; a medically-necessary, face-to-face encounter (one-on-one) between an established patient and a fqhc practitioner during which time one or more fqhc services are rendered and includes a typical bundle of medicare-covered services that would be furnished per diem to a patient receiving a fqhc visit | <1% | 765 | 590 | $11K |
44 more codes
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | <1% | 2,060 | $11K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | <1% | 163 | $9K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 1,464 | $8K |
| 92558 | <1% | 1,020 | $7K | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 5,063 | $7K |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 571 | $5K |
| 99177 | <1% | 792 | $5K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | <1% | 250 | $4K |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 495 | $4K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | <1% | 56 | $4K |
| 90834 | Psychotherapy session, about 45 minutes | <1% | 114 | $4K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 68 | $3K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | <1% | 61 | $3K |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,915 | $2K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 2,306 | $2K |
| 87807 | <1% | 148 | $2K | |
| J3301 | Injection, triamcinolone acetonide, not otherwise specified, 10 mg | <1% | 670 | $2K |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 2,845 | $1K |
| 92552 | <1% | 72 | $778.89 | |
| 99173 | <1% | 167 | $766.92 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 247 | $757.37 |
| 81003 | <1% | 503 | $691.79 | |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 21 | $682.12 |
| 90791 | Psychiatric diagnostic evaluation | <1% | 12 | $583.20 |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and allowed practitioners to affirm the initial implementation of the plan of care | <1% | 12 | $492.00 |
| 96160 | <1% | 17 | $425.25 | |
| 3079F | <1% | 961 | $400.00 | |
| J1010 | Injection, methylprednisolone acetate, 1 mg | <1% | 82 | $383.34 |
| 90686 | <1% | 107 | $326.86 | |
| 3075F | <1% | 674 | $300.00 | |
| 3078F | <1% | 244 | $300.00 | |
| 87400 | <1% | 41 | $261.92 | |
| 92551 | <1% | 31 | $195.94 | |
| 3074F | <1% | 254 | $130.00 | |
| J1020 | Injection, methylprednisolone acetate, 20 mg | <1% | 37 | $104.58 |
| 81002 | <1% | 29 | $98.80 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 16 | $77.70 |
| J2800 | Injection, methocarbamol, up to 10 ml | <1% | 20 | $57.39 |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 20 | $26.06 |
| 91301 | 0% | 19 | $0.00 | |
| 99070 | 0% | 20 | $0.00 | |
| 3044F | 0% | 20 | $0.00 | |
| 90677 | 0% | 18 | $0.00 | |
| 90674 | 0% | 28 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLOVETT, JAMES (EXECUTIVE DIRECTOR)
| Provider | Location | Paid |
|---|---|---|
| Mountain Peoples Health Councils INC. | Huntsville, TN | $1.17M |
| Mountain Peoples Health Councils INC | Oneida, TN | $954K |
| Mountain Peoples Health Councils INC | Winfield, TN | $424K |
| Mountain Peoples Health Councils INC | Huntsville, TN | $412K |
| Mountain Peoples Health Councils INC | Oneida, TN | $206K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.